Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adductor Canal Block vs Periarticular Injection for Pain After TKA
NCT02740192Phase 1Completed
- Sponsor
- Henry Ford Health
- Start
- Apr 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Henry Ford Health. Primary endpoints: Post-operative pain level (Visual Analog Scale) at 3 days, Knee flexion and extension Range of Motion at 3 days and 2 more. Started Apr 2016; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02740192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02740192.